Memorial Sloan Kettering Nassau (Limited Protocol Activities) — Uniondale, New York

Public research footprint of Memorial Sloan Kettering Nassau (Limited Protocol Activities), compiled from the ClinicalTrials.gov public registry.

545

Registered studies

414

Active

198

Recruiting now

105

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma · Endometrial Dedifferentiated Carcinoma · Endometrial Clear Cell Adenocarcinoma · Stage II Lung Non-Small Cell Cancer AJCC v7

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT06954337 — MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled… (Recruiting)
NCT06589804 — Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Memorial Sloan Kettering Nassau (Limited Protocol Activities)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.